Trial Profile
Efficacy and safety of Tacrolimus retard formulation- Envarsus in the heart transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2017
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Heart transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 22 Apr 2017 New trial record
- 08 Apr 2017 Results presented at the 37th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation